Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

Studies on two new vitamin D analogs, EB 1089 and KH 1060: effects on bone resorption and osteoclast recruitment in vitro.

Wiberg K, Ljunghall S, Binderup L, Ljunggren O.

Bone. 1995 Oct;17(4):391-5.

PMID:
8573413
[PubMed - indexed for MEDLINE]
2.

Differential effects of 1,25-dihydroxyvitamin D3-analogs on osteoblast-like cells and on in vitro bone resorption.

van den Bemd GJ, Pols HA, Birkenhäger JC, Kleinekoort WM, van Leeuwen JP.

J Steroid Biochem Mol Biol. 1995 Dec;55(3-4):337-46.

PMID:
8541230
[PubMed - indexed for MEDLINE]
3.

The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine.

Brown AJ, Finch J, Grieff M, Ritter C, Kubodera N, Nishii Y, Slatopolsky E.

Endocrinology. 1993 Sep;133(3):1158-64.

PMID:
8396012
[PubMed - indexed for MEDLINE]
4.

Ligand-dependent conformational changes in thyroid hormone and retinoic acid receptors are potentially enhanced by heterodimerization with retinoic X receptor.

Leng X, Tsai SY, O'Malley BW, Tsai MJ.

J Steroid Biochem Mol Biol. 1993 Dec;46(6):643-61.

PMID:
8274399
[PubMed - indexed for MEDLINE]
5.

Stabilization of the vitamin D receptor in rat osteosarcoma cells through the action of 1,25-dihydroxyvitamin D3.

Arbour NC, Prahl JM, DeLuca HF.

Mol Endocrinol. 1993 Oct;7(10):1307-12.

PMID:
8264662
[PubMed - indexed for MEDLINE]
6.

Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain.

Beekman JM, Allan GF, Tsai SY, Tsai MJ, O'Malley BW.

Mol Endocrinol. 1993 Oct;7(10):1266-74.

PMID:
8264659
[PubMed - indexed for MEDLINE]
7.

Different agonist- and antagonist-induced conformational changes in retinoic acid receptors analyzed by protease mapping.

Keidel S, LeMotte P, Apfel C.

Mol Cell Biol. 1994 Jan;14(1):287-98.

PMID:
8264595
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

All-trans retinoic acid and 1 alpha,25-dihydroxyvitamin D3 co-operate to promote differentiation of the human promyeloid leukemia cell line HL60 to monocytes.

Brown G, Bunce CM, Rowlands DC, Williams GR.

Leukemia. 1994 May;8(5):806-15.

PMID:
8182938
[PubMed - indexed for MEDLINE]
9.

Increased biological activity of 20-epi-1,25-dihydroxyvitamin D3 is due to reduced catabolism and altered protein binding.

Dilworth FJ, Calverley MJ, Makin HL, Jones G.

Biochem Pharmacol. 1994 Mar 15;47(6):987-93.

PMID:
8147918
[PubMed - indexed for MEDLINE]
10.

Two novel vitamin D analogues, KH 1060 and CB 966, prolong skin allograft survival in mice.

Veyron P, Pamphile R, Binderup L, Touraine JL.

Transpl Immunol. 1993;1(1):72-6.

PMID:
8081764
[PubMed - indexed for MEDLINE]
11.

1 alpha,25-Dihydroxy-20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro.

Elstner E, Lee YY, Hashiya M, Pakkala S, Binderup L, Norman AW, Okamura WH, Koeffler HP.

Blood. 1994 Sep 15;84(6):1960-7.

PMID:
8080998
[PubMed - indexed for MEDLINE]
Free Article
12.

Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen.

Vink-van Wijngaarden T, Pols HA, Buurman CJ, van den Bemd GJ, Dorssers LC, Birkenhäger JC, van Leeuwen JP.

Cancer Res. 1994 Nov 1;54(21):5711-7.

PMID:
7923220
[PubMed - indexed for MEDLINE]
Free Article
13.

Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060.

Mathieu C, Waer M, Casteels K, Laureys J, Bouillon R.

Endocrinology. 1995 Mar;136(3):866-72.

PMID:
7867594
[PubMed - indexed for MEDLINE]
14.

Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression.

Sasaki H, Harada H, Handa Y, Morino H, Suzawa M, Shimpo E, Katsumata T, Masuhiro Y, Matsuda K, Ebihara K, et al.

Biochemistry. 1995 Jan 10;34(1):370-7.

PMID:
7819220
[PubMed - indexed for MEDLINE]
15.

Structure-function relationships in the vitamin D endocrine system.

Bouillon R, Okamura WH, Norman AW.

Endocr Rev. 1995 Apr;16(2):200-57. Review. No abstract available.

PMID:
7781594
[PubMed - indexed for MEDLINE]
16.

Distinct conformational changes induced by 20-epi analogues of 1 alpha,25-dihydroxyvitamin D3 are associated with enhanced activation of the vitamin D receptor.

Peleg S, Sastry M, Collins ED, Bishop JE, Norman AW.

J Biol Chem. 1995 May 5;270(18):10551-8.

PMID:
7737990
[PubMed - indexed for MEDLINE]
Free Article
17.

The anti-proliferative effect of vitamin D3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity.

Nayeri S, Danielsson C, Kahlen JP, Schräder M, Mathiasen IS, Binderup L, Carlberg C.

Oncogene. 1995 Nov 2;11(9):1853-8.

PMID:
7478614
[PubMed - indexed for MEDLINE]
18.
19.

Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3.

Eisman JA, Barkla DH, Tutton PJ.

Cancer Res. 1987 Jan 1;47(1):21-5.

PMID:
3024816
[PubMed - indexed for MEDLINE]
Free Article
20.

Cloning and expression of full-length cDNA encoding human vitamin D receptor.

Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J, O'Malley BW.

Proc Natl Acad Sci U S A. 1988 May;85(10):3294-8.

PMID:
2835767
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk